Bill · H.R. 9790· House(119-HR-9790)
Modernizing Opioid Treatment Access Act 2.0 of 2026
- Introduced
- 7/20/2026
- Last activity
- 7/20/2026 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsored by
- Donald Norcross
- Cosponsors
- - 3 - 1
- Introduced
- In Committee
What this bill would do
This bill, known as the "Modernizing Opioid Treatment Access Act 2.0 of 2026," aims to expand access to methadone for treating opioid use disorder. It allows specific practitioners to prescribe methadone to be dispensed through pharmacies for supervised or unsupervised use. These practitioners must be licensed to prescribe controlled substances and meet specific board certification or Secretary-determined qualifications. The bill mandates that prescribing be done electronically for liquid or dispersible tablet formulations. It also allows for treatment via telemedicine and requires certain informed consent documentation.
Yes· 3 of 4
Does this do more about addiction and overdose deaths?+7
The bill directly addresses the opioid crisis by modernizing and expanding methadone access via alternative care models.
Does this make health care easier to get in general?+6
The bill expands access to methadone treatment through pharmacies and telemedicine.
Does this make what the government does easier for the public to see?+3
The bill requires the DEA to submit annual reports to Congress regarding methadone prescribing and pharmacy orders.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Expanded Treatment Options: The bill allows methadone to be dispensed through a pharmacy for an individual's own supervised or unsupervised use, which expands how people can access medication (Section 2, paragraph (2)(A)).
-
Access via Telemedicine: Maintenance or detoxification treatment can be provided through the practice of telemedicine, which may increase access for some individuals (Section 2, paragraph (2)(G)).
-
Simplified Pharmacy Process: Pharmacies are not required to obtain a separate registration to dispense methadone that has been prescribed by a registered practitioner under this act (Section 2, paragraph (2)(H)).
Potential Negative Impacts for People
-
Confidentiality Differences: Individuals must be informed of specific differences in confidentiality protections when dispensing through a pharmacy compared to an opioid treatment program (Section 2, paragraph (2)(E)(ii)).
-
State-Level Restrictions: A State has the power to request that the Attorney General cease registering, revoke existing registrations, or deny pending applications for these practitioners within that State (Section 2, paragraph (2)(F)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Opioid Crisis Response+7Improves Healthcare Access+6
- Governance And Ideology
- Improves Government Transparency+3Increase States Rights+2
- 9/16/2026
- 2 Cosponsors added.
- 7/20/2026
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2 Cosponsors added.
- Introduced in House
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Steve CohenDemocrat · Tennessee
Michael LawlerRepublican · New York
Summer LeeDemocrat · Pennsylvania
Paul TonkoDemocrat · New York